All Stories

  1. Simultaneous Modeling of Biomarker and Toxicity Response Predicted Optimal Regimen of Guadecitabine (SGI-110) in Myeloid Malignancies

    Article • CPT Pharmacometrics & Systems Pharmacology, September 2017, Wiley

    Pietro Taverna